20 plus years of expertise in developing APIs. Recognised for rich chemistry experience, quality, manufacturing capabilities, regulatory and IP capabilities

    Read more

  • Formulations

    One of the world leaders in developing & manufacturing branded/non-branded generics. More than 200 marketed products and 150 ANDAs filed across most therapeutic areas.

    Read more

  • ARV

    One of the world's largest global producer of anti-retroviral drugs. Over 30 approved ARV molecules and combinations in ARV portfolio.

    Read more

  • Biosimilars

    Our Biosimilar program focuses on development, manufacturing and commercialization of high value complex biosimilars including monoclonal antibodies.

    Read more

News & Events

  • 05 May 2017
  • Hetero receives generic Sofosbuvir+Velpatasvir approval for India
  • India, Hyderabad, 5th May, 2017: Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that it has received the approval for the generic version of ’Sofosbuvir+Velpatasvir’ combination from Drugs Controller General of India. Read more